Allelic losses in localized prostate cancer: Association with prognostic factors

Journal of Urology

Volumn 170, Issue 4 I, 2003, Pages 1394-1397

  Fromont, Gaëlle ^a,b   Joulin, Vincent ^a   Chantrel Groussard, Karine ^c   Vallancien, Guy ^b   Guillonneau, Bertrand ^b   Validire, Pierre ^b   Latil, Alain ^c   Cussenot, Olivier ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT MUTUALISTE MONTSOURIS   (France)

^c Parc Scientifique de Luminy   (France)

Author keywords

Prostate prostatic neoplasms loss of heterozygosity

Indexed keywords

MICROSATELLITE DNA; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ALLELISM; ARTICLE; CANCER INVASION; CHROMOSOME 12P; CHROMOSOME 13; CHROMOSOME 13Q; CHROMOSOME 16Q; CHROMOSOME 18; CHROMOSOME 18Q; CHROMOSOME 7Q; CHROMOSOME 8P; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DNA EXTRACTION; GENOTYPE; GLEASON SCORE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; PERINEURAL INVASION; PERINEURIUM; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM;

EID: 0042191696     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000083329.89215.91     Document Type: Article

References (20)

1. Landis, S. H., Murray, T., Bolden, S. and Wingo, P. A.: Cancer statistics, 1998. CA Cancer J Clin, 48: 6, 1998
2. Bostwick, D. G., Grignon, D. J., Hammond, M. E., Amin, M. B., Cohen, M., Crawford, D. et al: Prognostic factors of prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med, 124: 995, 2000
3. Endrizzi, J. and Seay, T.: The relationship between early biochemical failure and perineural invasion in pathological T2 prostate cancer. BJU Int, 85: 696, 2000
4. Ozcan, F.: Correlation of perineural invasion on radical prostatectomy specimens with other pathologic prognostic factors and PSA failure. Eur Urol, 40: 308, 2001
5. Latil, A., Cussenot, O., Fournier, G., Baron, J. C. and Lidereau, R.: Loss of heterozygoty at 7q31 is a frequent and early event in prostate cancer. Clin Cancer Res, 1: 1385, 1995
6. Kibel, A. S., Faith, D. A., Bova, G. S. and Isaacs, W. B.: Loss of heterozygosity at 12p12-13 in primary and metastatic prostate adenocarcinoma. J Urol, 164: 192, 2000
7. Oba, K., Matsuyama, H., Yoshihiro, S., Kishi, F., Takahashi, M., Tsukamoto, M. et al: Two putative tumor suppressor genes at chromosome arm 8p may play different roles in prostate cancer. Cancer Genet Cytogenet, 124: 20, 2001
8. Latil, A., Cussenot, O., Fournier, G., Driouch, K. and Lidereau, R.: Loss of heterozygosity at chromosome 16q in prostate cancer adenocarcinoma: identification of three independent regions. Cancer Res, 57: 1068, 1997
9. Latil, A., Bieche, I., Pesche, S., Volant, A., Valeri, A., Fournier, G. et al: Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer. Hum Pathol, 30: 809, 1999
10. Yin, Z., Babaian, R. J., Troncoso, P., Strom, S. S., Spitz, M. R., Caudell, J. J. et al: Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Oncogene, 20: 2273, 2001
11. Prasad, M. A., Trybus, T. M., Wojno, K. J. and Macoska, J. A.: Homozygous and frequent deletion of proximal 8p sequence in human prostate cancers: identification of a potential tumor suppressor gene site. Genes Chromosomes Cancer, 23: 255, 1998
12. Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A. et al: A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature, 380: 152, 1996
13. Matsuyama, H., Pan, Y., Oba, K., Yoshihiro, S., Matsuda, K., Hagarth, L. et al: Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer. Clin Cancer Res, 7: 3139, 2001
14. Tsuchiya, M., Slezak, J. M., Lieber, M. M., Bergstrahl, E. J. and Jenkins, R. B.: Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization in pathologic organ-confined prostate cancer. Genes Chromosomes Cancer, 34: 363, 2002
15. Zhou, W., Goodman, S. N., Galizia, G., Lieto, E., Ferraraccio, F., Pignatelli, C. et al: Counting alleles to predict recurrence of early stage colorectal cancer. Lancet, 359: 219, 2002
16. Hugel, A. and Wernert, N.: Loss of heterozygosity (LOH), malignant grade, and clonality in microdissected prostate cancer. Br J Cancer, 79: 551, 1999
17. Takanishi, D. M., Jr., Kim, S. Y., Kelemen, P. R., Yaremko, M. L., Kim, A. H., Ramesar, J. E. et al: Chromosome 8 losses in colorectal carcinoma: localization and correlation with invasive disease. Mol Diagn, 2: 3, 1997
18. Yang, G., Wheeler, T. M., Kattan, M. W., Scardino, P. T. and Thompson, T. C.: Perineural invasion of prostate carcinoma cells is associated with reduced apoptotic index. Cancer, 78: 1267, 1996
19. Ishii, H., Vecchione, A., Marakumo, Y., Baldassarre, G., Numata, S., Trapasso, F. et al: FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis. Proc Natl Acad Sci USA, 98: 10374, 2001
20. Xu, J., Zheng, S. L., Komiya, A., Mychaleckyj, J. C., Isaacs, S. D., Hu, J. J. et al: Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet, 32: 321, 2002